Efficacy and Safety of Adding Asciminib to the Standard-of-care for Post Allogenic Hematopoietic Stem-cell Transplant (HSCT) Maintenance in Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (Ph+ B-ALL) or Blastic Transformed CML (Myeloid or Lymphoid) (CML-BP)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07493408

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:28:08.050669+00:00

Published At

2026-03-25T00:00:00+00:00

Record Updated At

2026-03-25

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Ph+ Acute Lymphoblastic Leukemia (Ph+ALL)", "Blastic Transformation of Chronic Myeloid Leukemia", "Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (Ph+ B-ALL)", "Haematopoietic Stem Cell Transplant, Allogeneic"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-03-25"

protocolSection.identificationModule.nctId

"NCT07493408"

protocolSection.identificationModule.officialTitle

"Efficacy and Safety of Adding Asciminib to the Standard-of-care for Post Allogenic Hematopoietic Stem-cell Transplant (HSCT) Maintenance in Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (Ph+ B-ALL) or Blastic Transformed CML (Myeloid or Lymphoid) (CML-BP)"

protocolSection.statusModule.overallStatus

"NOT_YET_RECRUITING"

protocolSection.designModule.phases

["PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Ph+ Acute Lymphoblastic Leukemia (Ph+ALL) (protocolSection.conditionsModule.conditions)
• Blastic Transformation of Chronic Myeloid Leukemia (protocolSection.conditionsModule.conditions)
• Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (Ph+ B-ALL) (protocolSection.conditionsModule.conditions)
• Haematopoietic Stem Cell Transplant, Allogeneic (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.